Texas Health Dallas Selected as Magnet-Designated Genomics Site in National Study|
DALLAS — Texas Health Presbyterian Hospital Dallas has been selected to participate in a national study to advance genetics and genomic knowledge among nurses. This is the first study of its kind targeting registered nurses in Magnet-designated hospitals.
“We were excited to apply and very honored to be selected as the only Dallas Magnet hospital to participate in this innovative national research on genomics,” said Cole Edmonson, D.N.P., R.N., FACHE, NEA-BC, vice president of patient care services and chief nursing officer at Texas Health Dallas. “Nursing practice is dynamic and evolving at a record pace today, and we look forward to this opportunity to impact how nurses provide exceptional patient care and integrate genomics into practice.”
Texas Health Dallas is one of only two hospitals in North Texas and one of 21 medical centers nationally that were selected to participate in the study. The other participating North Texas hospital is Texas Health Harris Methodist Hospital Fort Worth. Only Magnet-designated hospitals were eligible for this project, as they hold the highest recognition by the American Nurses Credentialing Center for quality patient care, nursing excellence and innovations in professional nursing practice.
Funded by the National Council of State Boards of Nursing, the study — Expanding RN Scope of Practice: A Method for Introducing a New Competency into Nursing Practice — is designed to improve nursing care by increasing nurses’ understanding of how genetics and genomics personalizes healthcare.
“While genetics is the study of individual genes and their impact on single gene disorders, genomics is the study of all the genes in the human genome and their interactions with each other, the environment and the influence of other factors,” said Patricia Kelly, D.N.P., APRN, C.N.S., AOCN® , a researcher and genomics consultant at Texas Health Dallas. “Nurses are currently using genomics information in their daily practice, often without realizing it.”
Edmonson and Kelly have been named principal investigators and Magnet Champion Dyads for the Dallas site.
The introductory phase of the program includes completing baseline genetic and genomic competency surveys. As part of the program, Edmonson and Kelly will use the survey information to plan a year-long program of education, networking, and follow- up on successful learning opportunities at Texas Health Dallas.
Edmonson and Kelly will attend the first kick-off training meeting Sept. 6-7 in Washington, D.C.
About Texas Health Presbyterian Hospital Dallas